Literature DB >> 1099121

Hereditary deficiency of the seventh component of complement.

J T Boyer, E P Gall, M E Norman, U R Nilsson, T S Zimmerman.   

Abstract

Deficiency of the seventh component of complement has been found in the serum of a 42-yr-old Caucasian woman who has Raynaud's phenomenon, sclerodactyly, and telangiectasia. Partial deficiency was found in the serum of the patient's parents and children, indicating a pattern of inheritance of autosomal codominance. Transfusion experiments indicated that exogenous C7 had a 91-h halk-life in the patient. There was no evidence for C7 synthesis after transfusion. No C7 inhibitors were detected in the patient's serum. The patient's serum was found to support the activation of complement by both the classical and properdin pathways to the C7 stage. The addition of C7 to the patient's serum permitted it to support hemolytic reactions initiated by either pathway. No defects could be detected in plasma or whole blood coagulation. The patient's serum was deficient in opsonizing unsensitized yeast particles in serum and in the generation of chemotactic factor by antigen-antibody complexes and endotoxin. Both deficiencies were corrected by the addition of C7. These observations suggest a key role for C7 for in vitro yeast phagocytosis and chemotaxis generation. However, the patient's lack of infections indicates a relatively minor role for C7 in human resistance to infection.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1099121      PMCID: PMC301946          DOI: 10.1172/JCI108170

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  von Willebrand's disease.

Authors:  M BLOMBACK; J E JORPES; I M NILSSON
Journal:  Am J Med       Date:  1963-02       Impact factor: 4.965

2.  Studies on the mode of action of the fifth, sixth and seventh component of human complement in immune haemolysis.

Authors:  U R Nilsson; H J Müller-Eberhard
Journal:  Immunology       Date:  1967-07       Impact factor: 7.397

3.  Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.

Authors:  I Gigli; R A Nelson
Journal:  Exp Cell Res       Date:  1968-07       Impact factor: 3.905

4.  A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5).

Authors:  M E Miller; U R Nilsson
Journal:  N Engl J Med       Date:  1970-02-12       Impact factor: 91.245

5.  The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.

Authors:  P J Lachmann; A B Kay; R A Thompson
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

6.  Complement and cold agglutinins. II. Interactions of the components of complement and antibody within the haemolytic complex.

Authors:  J T Boyer
Journal:  Clin Exp Immunol       Date:  1967-03       Impact factor: 4.330

7.  Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies.

Authors:  J P Leddy; M M Frank; T Gaither; J Baum; M R Klemperer
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

8.  Hereditary deficiency of the sixth component of complement in man. II. Studies of hemostasis.

Authors:  R S Heusinkveld; J P Leddy; M R Klemperer; R T Breckenridge
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

9.  Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.

Authors:  R A Thompson; P J Lachmann
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

10.  Deficiency of the sixth component of complement in rabbits with an inherited complement defect.

Authors:  K Rother; U Rother; H J Müller-Eberhard; J R Nilsson
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  18 in total

1.  Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.

Authors:  H E Jasin
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

2.  Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.

Authors:  S I Rosenfeld; M E Kelly; J P Leddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

3.  How partial C7 deficiency with chronic and recurrent bacterial infections can mimic total C7 deficiency: temporary restoration of host C7 levels following plasma transfusion.

Authors:  R Würzner; A E Platonov; V B Beloborodov; A I Pereverzev; I V Vershinina; B A Fernie; M J Hobart; P J Lachmann; A Orren
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

4.  Clinical and immunological studies in a case of selective complete C1q deficiency.

Authors:  A I Berkel; M Loos; O Sanal; G Mauff; Y Güngen; U Ors; F Ersoy; O Yegin
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

5.  Abnormal platelet function in C3-deficient mice.

Authors:  F C Gushiken; H Han; J Li; R E Rumbaut; V Afshar-Kharghan
Journal:  J Thromb Haemost       Date:  2009-03-05       Impact factor: 5.824

6.  Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.

Authors:  B H Petersen; J A Graham; G F Brooks
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

7.  Human platelet-initiated formation and uptake of the C5-9 complex of human complement.

Authors:  T S Zimmerman; W P Kolb
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

8.  Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.

Authors:  G R Nemerow; H Gewurz; S G Osofsky; T F Lint
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

9.  Hereditary C7 deficiency. Diagnosis and HLA studies in a French-Canadian family.

Authors:  J M Delâge; P Bergeron; J Simard; G Lehner-Netsch; E Prochazka
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

Review 10.  Clinical conditions associated with defective polymorphonuclear leukocyte chemotaxis.

Authors:  P G Quie; K L Cates
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.